News Conference News AHA 2017 Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation Yael L. Maxwell November 27, 2017
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News AHA 2017 Accelerator-2: Streamlined Regional STEMI Care Speeds Up Treatment, Lowers Mortality Michael O'Riordan November 14, 2017
News Conference News AHA 2017 TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery Shelley Wood November 12, 2017
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News ESC 2017 Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI Michael O'Riordan August 28, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017
News Conference News ESC 2017 Mortality After Acute MI Halved Over Two Decades in Switzerland, With Greatest Gains by Women Michael O'Riordan August 26, 2017
News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Conference News ACC 2017 Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests Todd Neale March 22, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI Todd Neale March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term Michael O'Riordan March 10, 2017
News Conference News ACC 2017 Erectile Dysfunction Meds Linked to Fewer Death and HF Hospitalizations After MI L.A. McKeown March 09, 2017